nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—ACE—polycystic ovary syndrome	0.839	1	CbGaD
Fosinopril—ACE—tunica intima—polycystic ovary syndrome	0.0203	0.319	CbGeAlD
Fosinopril—ACE—urine—polycystic ovary syndrome	0.00999	0.157	CbGeAlD
Fosinopril—Anaemia megaloblastic—Metformin—polycystic ovary syndrome	0.00941	0.105	CcSEcCtD
Fosinopril—Abnormal faeces—Metformin—polycystic ovary syndrome	0.00776	0.0868	CcSEcCtD
Fosinopril—Respiratory distress—Metformin—polycystic ovary syndrome	0.00349	0.039	CcSEcCtD
Fosinopril—Nail disorder—Metformin—polycystic ovary syndrome	0.00342	0.0382	CcSEcCtD
Fosinopril—SLC15A1—endometrium—polycystic ovary syndrome	0.00329	0.0517	CbGeAlD
Fosinopril—ACE—embryo—polycystic ovary syndrome	0.00323	0.0507	CbGeAlD
Fosinopril—Heartburn—Metformin—polycystic ovary syndrome	0.00322	0.036	CcSEcCtD
Fosinopril—SLC15A1—vagina—polycystic ovary syndrome	0.00247	0.0388	CbGeAlD
Fosinopril—ACE—endometrium—polycystic ovary syndrome	0.00236	0.0371	CbGeAlD
Fosinopril—SLC15A1—endocrine gland—polycystic ovary syndrome	0.00231	0.0363	CbGeAlD
Fosinopril—ACE—pituitary gland—polycystic ovary syndrome	0.00214	0.0336	CbGeAlD
Fosinopril—ACE—adipose tissue—polycystic ovary syndrome	0.00213	0.0334	CbGeAlD
Fosinopril—Neuropathy—Metformin—polycystic ovary syndrome	0.00208	0.0233	CcSEcCtD
Fosinopril—SLC15A2—endometrium—polycystic ovary syndrome	0.00206	0.0323	CbGeAlD
Fosinopril—Lightheadedness—Metformin—polycystic ovary syndrome	0.00198	0.0222	CcSEcCtD
Fosinopril—ACE—adrenal gland—polycystic ovary syndrome	0.00191	0.03	CbGeAlD
Fosinopril—Ear pain—Metformin—polycystic ovary syndrome	0.00189	0.0211	CcSEcCtD
Fosinopril—SLC15A2—pituitary gland—polycystic ovary syndrome	0.00186	0.0293	CbGeAlD
Fosinopril—ACE—female gonad—polycystic ovary syndrome	0.00178	0.028	CbGeAlD
Fosinopril—Injury—Metformin—polycystic ovary syndrome	0.00175	0.0196	CcSEcCtD
Fosinopril—SLC15A2—adrenal gland—polycystic ovary syndrome	0.00167	0.0261	CbGeAlD
Fosinopril—ACE—endocrine gland—polycystic ovary syndrome	0.00166	0.026	CbGeAlD
Fosinopril—SLC15A2—female gonad—polycystic ovary syndrome	0.00155	0.0244	CbGeAlD
Fosinopril—SLC15A2—vagina—polycystic ovary syndrome	0.00154	0.0242	CbGeAlD
Fosinopril—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00147	0.0164	CcSEcCtD
Fosinopril—Breast disorder—Metformin—polycystic ovary syndrome	0.00145	0.0163	CcSEcCtD
Fosinopril—Cramp muscle—Metformin—polycystic ovary syndrome	0.00145	0.0162	CcSEcCtD
Fosinopril—SLC15A2—endocrine gland—polycystic ovary syndrome	0.00144	0.0227	CbGeAlD
Fosinopril—Abdominal distension—Metformin—polycystic ovary syndrome	0.0014	0.0157	CcSEcCtD
Fosinopril—Influenza—Metformin—polycystic ovary syndrome	0.00139	0.0156	CcSEcCtD
Fosinopril—Pancreatitis—Metformin—polycystic ovary syndrome	0.00136	0.0153	CcSEcCtD
Fosinopril—Angina pectoris—Metformin—polycystic ovary syndrome	0.00135	0.0152	CcSEcCtD
Fosinopril—Sweating increased—Metformin—polycystic ovary syndrome	0.00135	0.0152	CcSEcCtD
Fosinopril—Neutropenia—Metformin—polycystic ovary syndrome	0.0013	0.0146	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00129	0.0145	CcSEcCtD
Fosinopril—Drowsiness—Metformin—polycystic ovary syndrome	0.00124	0.0139	CcSEcCtD
Fosinopril—Spirapril—ACE—polycystic ovary syndrome	0.00122	0.163	CrCbGaD
Fosinopril—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00122	0.0136	CcSEcCtD
Fosinopril—Mitiglinide—PPARG—polycystic ovary syndrome	0.00117	0.156	CrCbGaD
Fosinopril—Bradycardia—Metformin—polycystic ovary syndrome	0.00113	0.0127	CcSEcCtD
Fosinopril—Rhinitis—Metformin—polycystic ovary syndrome	0.00112	0.0125	CcSEcCtD
Fosinopril—Hepatitis—Metformin—polycystic ovary syndrome	0.00111	0.0125	CcSEcCtD
Fosinopril—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00111	0.0124	CcSEcCtD
Fosinopril—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0011	0.0123	CcSEcCtD
Fosinopril—Cilazapril—ACE—polycystic ovary syndrome	0.00109	0.146	CrCbGaD
Fosinopril—Lisinopril—ACE—polycystic ovary syndrome	0.00109	0.146	CrCbGaD
Fosinopril—Ramipril—ACE—polycystic ovary syndrome	0.00106	0.141	CrCbGaD
Fosinopril—Trandolapril—ACE—polycystic ovary syndrome	0.00106	0.141	CrCbGaD
Fosinopril—Flushing—Metformin—polycystic ovary syndrome	0.00103	0.0116	CcSEcCtD
Fosinopril—Chills—Metformin—polycystic ovary syndrome	0.000999	0.0112	CcSEcCtD
Fosinopril—Flatulence—Metformin—polycystic ovary syndrome	0.000955	0.0107	CcSEcCtD
Fosinopril—Dysgeusia—Metformin—polycystic ovary syndrome	0.000949	0.0106	CcSEcCtD
Fosinopril—Muscle spasms—Metformin—polycystic ovary syndrome	0.000932	0.0104	CcSEcCtD
Fosinopril—Vision blurred—Metformin—polycystic ovary syndrome	0.000913	0.0102	CcSEcCtD
Fosinopril—Tremor—Metformin—polycystic ovary syndrome	0.000908	0.0102	CcSEcCtD
Fosinopril—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000899	0.0101	CcSEcCtD
Fosinopril—Malaise—Metformin—polycystic ovary syndrome	0.000874	0.00978	CcSEcCtD
Fosinopril—Syncope—Metformin—polycystic ovary syndrome	0.000869	0.00972	CcSEcCtD
Fosinopril—Palpitations—Metformin—polycystic ovary syndrome	0.000857	0.00958	CcSEcCtD
Fosinopril—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000852	0.00953	CcSEcCtD
Fosinopril—Hypertension—Metformin—polycystic ovary syndrome	0.000837	0.00936	CcSEcCtD
Fosinopril—Myalgia—Metformin—polycystic ovary syndrome	0.000825	0.00923	CcSEcCtD
Fosinopril—Chest pain—Metformin—polycystic ovary syndrome	0.000825	0.00923	CcSEcCtD
Fosinopril—Discomfort—Metformin—polycystic ovary syndrome	0.000815	0.00912	CcSEcCtD
Fosinopril—Enalapril—ACE—polycystic ovary syndrome	0.0008	0.107	CrCbGaD
Fosinopril—Oedema—Metformin—polycystic ovary syndrome	0.000791	0.00885	CcSEcCtD
Fosinopril—Infection—Metformin—polycystic ovary syndrome	0.000786	0.00879	CcSEcCtD
Fosinopril—Shock—Metformin—polycystic ovary syndrome	0.000778	0.00871	CcSEcCtD
Fosinopril—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000774	0.00867	CcSEcCtD
Fosinopril—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000765	0.00856	CcSEcCtD
Fosinopril—Anorexia—Metformin—polycystic ovary syndrome	0.000754	0.00844	CcSEcCtD
Fosinopril—Hypotension—Metformin—polycystic ovary syndrome	0.000739	0.00827	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000721	0.00806	CcSEcCtD
Fosinopril—Paraesthesia—Metformin—polycystic ovary syndrome	0.00071	0.00795	CcSEcCtD
Fosinopril—Dyspnoea—Metformin—polycystic ovary syndrome	0.000705	0.00789	CcSEcCtD
Fosinopril—Somnolence—Metformin—polycystic ovary syndrome	0.000703	0.00787	CcSEcCtD
Fosinopril—Dyspepsia—Metformin—polycystic ovary syndrome	0.000696	0.00779	CcSEcCtD
Fosinopril—Decreased appetite—Metformin—polycystic ovary syndrome	0.000688	0.00769	CcSEcCtD
Fosinopril—Fatigue—Metformin—polycystic ovary syndrome	0.000682	0.00763	CcSEcCtD
Fosinopril—Constipation—Metformin—polycystic ovary syndrome	0.000676	0.00757	CcSEcCtD
Fosinopril—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000652	0.00729	CcSEcCtD
Fosinopril—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000647	0.00724	CcSEcCtD
Fosinopril—Urticaria—Metformin—polycystic ovary syndrome	0.000628	0.00703	CcSEcCtD
Fosinopril—Abdominal pain—Metformin—polycystic ovary syndrome	0.000625	0.007	CcSEcCtD
Fosinopril—Asthenia—Metformin—polycystic ovary syndrome	0.000568	0.00635	CcSEcCtD
Fosinopril—Pruritus—Metformin—polycystic ovary syndrome	0.00056	0.00626	CcSEcCtD
Fosinopril—Diarrhoea—Metformin—polycystic ovary syndrome	0.000541	0.00606	CcSEcCtD
Fosinopril—Dizziness—Metformin—polycystic ovary syndrome	0.000523	0.00585	CcSEcCtD
Fosinopril—Vomiting—Metformin—polycystic ovary syndrome	0.000503	0.00563	CcSEcCtD
Fosinopril—Rash—Metformin—polycystic ovary syndrome	0.000499	0.00558	CcSEcCtD
Fosinopril—Dermatitis—Metformin—polycystic ovary syndrome	0.000498	0.00557	CcSEcCtD
Fosinopril—Headache—Metformin—polycystic ovary syndrome	0.000496	0.00554	CcSEcCtD
Fosinopril—Nausea—Metformin—polycystic ovary syndrome	0.00047	0.00526	CcSEcCtD
